These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16635606)

  • 1. Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study).
    Serebruany VL; Miller M; Pokov AN; Malinin AI; Lowry DR; Tanguay JF; Hennekens CH
    Am J Cardiol; 2006 May; 97(9):1332-6. PubMed ID: 16635606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
    Serebruany VL; Midei MG; Malinin AI; Oshrine BR; Lowry DR; Sane DC; Tanguay JF; Steinhubl SR; Berger PB; O'Connor CM; Hennekens CH
    Arch Intern Med; 2004 Oct; 164(18):2051-7. PubMed ID: 15477442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
    Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
    Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1).
    Jurk K; Jahn UR; Van Aken H; Schriek C; Droste DW; Ritter MA; Bernd Ringelstein E; Kehrel BE
    Thromb Haemost; 2004 Feb; 91(2):334-44. PubMed ID: 14961162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1.
    Keuren JF; Wielders SJ; Ulrichts H; Hackeng T; Heemskerk JW; Deckmyn H; Bevers EM; Lindhout T
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1499-505. PubMed ID: 15845904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor-induced Akt activation--regulation and possible function.
    Reséndiz JC; Kroll MH; Lassila R
    J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.
    Diaz-Ricart M; Fuste B; Estebanell E; Tonda R; Lozano M; Escolar G; Jamieson G; Ordinas A
    Platelets; 2005 Dec; 16(8):453-61. PubMed ID: 16287612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
    Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
    J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin and C reactive protein modulate protease- activated receptor-1 expression in vitro blood platelets.
    Chu LX; Zhou SX; Yang F; Qin YQ; Liang ZS; Mo CG; Wang XD; Xie J; He LP
    Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):75-80. PubMed ID: 26950455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of thrombin generation and clot bound thrombin in plasma of hyperlipidemic patients treated with statins].
    Michalska M; Chojnowska-Jezierska J; Broncel M; Marczyk I; Sikora J; Kostka B
    Przegl Lek; 2005; 62 Suppl 3():42-5. PubMed ID: 16521918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intraplatelet signaling enhances the release of human platelet PAR-1 and -4 amino-terminal peptides in response to thrombin.
    Ofosu FA; Dewar L; Song Y; Cedrone AC; Hortelano G; Craven SJ
    Biochemistry; 2009 Feb; 48(7):1562-72. PubMed ID: 19182900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.